Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Teva
Cantor Fitzgerald
Colorcon
Cipla
Julphar
Farmers Insurance
AstraZeneca
Fuji

Generated: October 24, 2017

DrugPatentWatch Database Preview

VOGELXO Drug Profile

« Back to Dashboard

Which patents cover Vogelxo, and what generic Vogelxo alternatives are available?

Vogelxo is a drug marketed by Upsher-smith Labs and is included in one NDA. There are three patents protecting this drug.

This drug has seven patent family members in seven countries.

The generic ingredient in VOGELXO is testosterone. There are sixty-two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the testosterone profile page.

Summary for Tradename: VOGELXO

US Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list53
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VOGELXO at DailyMed

Pharmacology for Tradename: VOGELXO

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs
VOGELXO
testosterone
GEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo► Subscribe► SubscribeY ► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo► Subscribe► SubscribeY ► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo► Subscribe► SubscribeY ► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo► Subscribe► SubscribeY ► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo► Subscribe► SubscribeY ► Subscribe
Upsher-smith Labs
VOGELXO
testosterone
GEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VOGELXO

Country Document Number Estimated Expiration
Singapore11201604788U► Subscribe
World Intellectual Property Organization (WIPO)2015089289► Subscribe
Australia2014362275► Subscribe
European Patent Office3079703► Subscribe
Israel246134► Subscribe
Canada2857286► Subscribe
Hong Kong1223852► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
US Army
QuintilesIMS
Farmers Insurance
Johnson and Johnson
Chinese Patent Office
Argus Health
McKesson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot